Strides Gets 483 for Quality Problems By Sam | July 3, 2017 Bangalore-based pharmaceutical company Strides Sashun, formerly known as Strides Arcolab, was recently cited by the FDA for quality problems with pills bound for U.S. markets. Source: Drug GMP Report Posted in Drug GMP Report